Medicare Competitive Bidding Savings For Single-Source Drugs Questioned

Competitive bidding for Medicare Part B drugs may not result in sufficient savings for certain single-source drugs, an AstraZeneca attorney told the Centers for Medicare & Medicaid Services April 20

More from Archive

More from Pink Sheet